Form 4: Conduit Pharmaceuticals Director Chele Chiavacci Farley Reports Share Acquisition and Disposal
SEC Form 4
Director Chele Chiavacci Farley reports acquiring and disposing of shares of Conduit Pharmaceuticals on June 11, 2024.
Summary
- On June 11, 2024, Chele Chiavacci Farley, a director of Conduit Pharmaceuticals Inc. [CDT], reported a transaction involving the company's common stock.
- Farley acquired 37,272 shares of common stock.
- Farley disposed of shares of common stock.
- Following the reported transaction, Farley beneficially owns 52,272 shares.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions by a company director. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This filing is a routine disclosure related to insider trading activity, which is common for directors and officers of publicly traded companies. It provides transparency to investors regarding the trading activities of company insiders.
Stakeholder Impact
- The transaction may be of interest to shareholders as it provides insight into the actions of a company director.
Key Dates
| Date | Description |
|---|---|
| 06/11/2024 | Date of the reported transaction (acquisition and disposal of shares). |
Keywords
Form 4, Beneficial Ownership, Director, CDT, Conduit Pharmaceuticals, Chele Chiavacci Farley, Share Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.